You are here: Industry Insights > retinal

News List

NGM to Focus on Novel Medicines for Retinal and Cardiovascular and Metabolic Diseases in Collaboration with Merck americanpharmaceuticalreview
July 05, 2021
GM Biopharmaceuticals, Inc. announced that the company has entered into an amended and restated agreement with Merck to extend their ongoing collaboration through March 2024 but with a narrower scope.
Path-breaking Study Reports High Sensitivity in Diabetic Retinopathy Screening Using Smartphones and Automated-AI in Primary-Care: Remidio Innovative Solutions En-CPhI.CN
October 11, 2019
Nearly 50% of patients with diabetes fail to get an annual eye examination done even in the US and EU.
Boehringer and Inflammasome to develop retinal therapies pharmaceutical-technology
September 24, 2019
The alliance will leverage Inflammasome’s intravitreal (IVT) drug delivery technologies to develop compounds in Boehringer’s retinal disease pipeline portfolio.
Retinal Vein Occlusion Linked to Higher Risk for CV Events drugs
September 10, 2019
Retinal vein occlusion (RVO) is associated with an increased risk for cardiovascular events and all-cause mortality, according to a review published in the September issue of Retina.
Don’t miss out on the chance to compete amongst the best in the industry pharmatimes
January 04, 2019
Exonate has successfully fundraised £1.5 million to accelerate development of its lead product - an eye drop treatment for retinal neovascular diseases.